Medibis is founded on a vision: making high quality, effective cannabinoid medicine accessible to patients. Our fully integrated business model is built with this ideal at its core, with patient outcomes guiding everything that we do.
We sit apart with our science-based approach. Medibis quality starts with the best genetics, strengthened by detailed analytics, and validated with clinical evidence.
We’re now bringing proven medicinal cannabis products to market, and launching our own trials, with a particular focus on treatments supporting mental health conditions and ASD. We’re deeply invested in our most important people - Australian patients.